RPID

Rapid Micro Biosystems Inc

RPID, USA

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

https://www.rapidmicrobio.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
RPID
stock
RPID

Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) 37% Jump Shows Its Popularity With Investors simplywall.st

Read more →
RPID
stock
RPID

November 2025 Penny Stock Opportunities For Savvy Investors simplywall.st

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$8

Analyst Picks

Strong Buy

3

Buy

0

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

3.66

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-25.95 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-13.63 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-116.41 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

0.90

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 38.41% of the total shares of Rapid Micro Biosystems Inc

1.

Bain Capital Life Sciences Investors, LLC

(19.0783%)

since

2025/06/30

3.

Schonfeld Strategic Advisors LLC

(2.3471%)

since

2025/06/30

4.

Parkman Healthcare Partners LLC

(2.0661%)

since

2025/06/30

5.

Vanguard Group Inc

(2.0456%)

since

2025/06/30

6.

Vanguard Total Stock Mkt Idx Inv

(1.4482%)

since

2025/07/31

7.

Advent International LP

(1.3069%)

since

2025/06/30

8.

BlackRock Inc

(1.0785%)

since

2025/06/30

9.

BlackRock Health Sciences Term Trust

(0.7534%)

since

2025/06/30

10.

Geode Capital Management, LLC

(0.4616%)

since

2025/06/30

11.

IMC US Ultra Micro Cap

(0.4109%)

since

2025/07/31

12.

Vanguard Institutional Extnd Mkt Idx Tr

(0.3849%)

since

2025/07/31

14.

Renaissance Technologies Corp

(0.251%)

since

2025/06/30

15.

Fidelity Extended Market Index

(0.2138%)

since

2025/07/31

16.

Pleiades Small Cap Equity A

(0.2054%)

since

2025/06/30

17.

iShares Micro-Cap ETF

(0.1507%)

since

2025/08/31

18.

Essex Investment Management Company, LLC

(0.141%)

since

2025/06/30

19.

State Street Corp

(0.1354%)

since

2025/06/30

20.

Extended Equity Market Fund K

(0.1324%)

since

2025/06/30

21.

Susquehanna International Group, LLP

(0.1173%)

since

2025/06/30

22.

Northern Trust Corp

(0.1098%)

since

2025/06/30

23.

Evernest Financial Advisors LLC

(0.0995%)

since

2025/06/30

24.

XTX Topco Ltd

(0.0945%)

since

2025/06/30

25.

Dimensional Fund Advisors, Inc.

(0.0914%)

since

2025/06/30

26.

Morgan Stanley - Brokerage Accounts

(0.0819%)

since

2025/06/30

27.

NT Ext Equity Mkt Idx Fd - L

(0.0656%)

since

2025/06/30

28.

Northern Trust Extended Eq Market Idx

(0.0656%)

since

2025/06/30

29.

Fidelity Total Market Index

(0.0649%)

since

2025/07/31

30.

Fidelity Series Total Market Index

(0.0565%)

since

2025/07/31

31.

Spartan Extended Market Index Pool F

(0.0499%)

since

2025/07/31

32.

Fidelity Nasdaq Composite Index

(0.0487%)

since

2025/07/31

33.

Citadel Advisors Llc

(0.047%)

since

2025/06/30

34.

Mariner Wealth Advisors LLC

(0.0457%)

since

2025/06/30

35.

Avantis US Small Cap Equity ETF

(0.0383%)

since

2025/08/30

36.

Essex Inv Mgt Micro Cap Growth

(0.0332%)

since

2025/03/31

37.

Dimensional US Targeted Value ETF

(0.0331%)

since

2025/08/29

38.

NT Ext Equity Mkt Idx Fd - NL

(0.032%)

since

2025/06/30

39.

Vanguard Instl Ttl Stk Mkt Idx InstlPls

(0.0319%)

since

2025/07/31

40.

Spartan Total Market Index Pool G

(0.0289%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.2175

Latest Release

Date

2025-09-30

EPS Actual

-0.26

EPS Estimate

-0.25

EPS Difference

-0.01

Surprise Percent

-4%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(3)
Defensive
Highly Defensive(6.5)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(4.3)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(1.5)
Momentum
Moderate Momentum(3.5)
Net Net
Not Undervalued (Net-Net)(1)
Quality
Low Quality Business(2.5)
Value
Overpriced(3)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.